Patents by Inventor Gary Hayter

Gary Hayter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250000394
    Abstract: Methods and apparatus for acquiring data associated with a monitored analyte level, determining a glucose level based at least in part on the acquired data associated with the monitored analyte level, manipulating a data set based on a processing mode following the glucose level determination, where the processing mode includes one of a data set transmission and output display, a data set storing and output display without transmission, or a data set transmission and data set storing without output display are provided.
    Type: Application
    Filed: September 13, 2024
    Publication date: January 2, 2025
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Gary A. Hayter
  • Patent number: 12178617
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: December 31, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20240423558
    Abstract: Improved alarms for analyte monitoring systems are provided. For example, disclosed herein are various embodiments of methods, systems, and interfaces for long hyperglycemic alerts or pre-alerts. In addition, various embodiments of methods, systems, and interfaces for modified high glucose alerts, which predict if the high glucose episode is associated with a recently administered medication dose are described. Also, systems that include both high glucose alerts and long hyperglycemic alert options are described, in addition to enabling and disabling or suppressing certain alerts under various conditions.
    Type: Application
    Filed: June 24, 2024
    Publication date: December 26, 2024
    Inventors: Erwin S. Budiman, Sediqeh Samadi, Aparajita Bhattacharya, Gary A. Hayter
  • Publication number: 20240407736
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: August 21, 2024
    Publication date: December 12, 2024
    Inventors: Timothy C. DUNN, Kenneth J. DONIGER, Glenn BERMAN, Gary A. HAYTER, Erwin S. BUDIMAN, Daniel M. BERNSTEIN, Nathan CROUTHER
  • Publication number: 20240374173
    Abstract: Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.
    Type: Application
    Filed: July 22, 2024
    Publication date: November 14, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Yongjin Xu, Timothy C. Dunn, Gary Hayter
  • Publication number: 20240358919
    Abstract: Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.
    Type: Application
    Filed: July 5, 2024
    Publication date: October 31, 2024
    Inventors: Erwin S. BUDIMAN, Gary A. HAYTER, Nathan C. CROUTHER, Marc B. TAUB, Wesley Scott HARPER, Charles WEI
  • Patent number: 12112854
    Abstract: Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: October 8, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Daniel M. Bernstein, Brittany K. Bradrick, Erwin S. Budiman, Eric Davis, Timothy C. Dunn, Mani Gopal, Wesley S. Harper, Gary A. Hayter, Steve Scott, Todd Winkler, Howard Wolpert
  • Patent number: 12102454
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: October 1, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Patent number: 12042276
    Abstract: Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.
    Type: Grant
    Filed: August 8, 2022
    Date of Patent: July 23, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Yongjin Xu, Timothy C. Dunn, Gary Hayter
  • Publication number: 20240225535
    Abstract: Systems, devices and methods are provided for titration of a medication dose for a patient or user. The titration may be based on determining a hypoglycemic risk of a user for a plurality of time-of-day periods. The determination of the hypoglycemic risk may be accomplished by known methods, including the glucose pattern analysis, glucose dysregulation analysis, low alarm frequency analysis, and combinations thereof. The system may then select a recommended action based on the analyte pattern type. The system may then store an indicator of the recommended action in a computer memory for output. The system may then output the recommended action. The recommended action may be outputted to the user, an HCP, or a caregiver. The recommended action may also vary depending on who is receiving the recommended action.
    Type: Application
    Filed: November 16, 2023
    Publication date: July 11, 2024
    Inventors: Matthew T. Novak, Aparajita Bhattacharya, Gary A. Hayter
  • Publication number: 20240215871
    Abstract: Systems, devices, and methods for detecting and measuring an amount of time an individual is within a predetermined analyte range based on analyte measurements. These results and related information are presented to the individual to show the individual an analyte response associated with consumed meals, or change in an analyte level within a predetermined time period after meals are consumed. These results can be organized based on a ranking system so as to allow the individual to visualize analyte responses and range impact associated with the meals. Various embodiments disclosed herein relate to methods, systems, and software applications intended to engage an individual by providing direct and timely feedback regarding the individual's meal-related analyte response.
    Type: Application
    Filed: October 16, 2023
    Publication date: July 4, 2024
    Inventors: Gary A. Hayter, Jeffrey Nishida-Boucher, Vyshnnavi Parthasarathy, Prarthana Prashanth, Saranpreet S. Nagra, Panganamala Ashwin Kumar, Sabine Kabel-Eckes, Rene S. Shabastari, Chano Y. Puente de la Vega, Leena Narayana, Jonathan Wood, Shreya Gupta, Genaro S. Sepulveda, Jose D. Vega, Jessica Rose Floeh, Vrunjal K. Mehta, Cristina Congote, Andrew M. Revoltar, Prashanth Chodagiri
  • Publication number: 20240206772
    Abstract: An analyte monitoring system and method for an on-body sensor control device may have a capability for sensing two or more analytes of a patient includes a processor and memory with instructions for determining various machine states and outputs based on time-correlated sensor data for each of the analytes. The states and outputs may include: an alert condition for one or more analytes; an advisory message; a correction to an analyte state estimate; an indication of a malfunction of the sensor control device, a malfunction of an insulin delivery device, a medication dose calculation; or an analytical report. Examples of the system and method for dual analytes comprising glucose and ketone are described. Data may be transmitted from the sensor control device to a reader device for output to a user.
    Type: Application
    Filed: December 21, 2023
    Publication date: June 27, 2024
    Inventors: Gary A. Hayter, Erwin S. Budiman, Marc B. Taub, Wesley Scott Harper
  • Publication number: 20240033427
    Abstract: Systems, devices and methods are provided for incorporating a medication delivery device into an integrated management system. The integrated management system may be an integrated diabetes management system and may include a glucose monitor, a connected insulin pen, and software. The integrated management system may produce a plurality of reports that may include data related to analyte levels (e.g., glucose levels) and medication delivered (e.g., insulin delivered). The medication delivery device may also provide feedback to the user.
    Type: Application
    Filed: July 26, 2023
    Publication date: February 1, 2024
    Inventors: Erwin S. Budiman, Matthew T. Novak, Gary A. Hayter
  • Publication number: 20230414136
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Application
    Filed: September 11, 2023
    Publication date: December 28, 2023
    Inventor: Gary A. Hayter
  • Publication number: 20230346269
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Application
    Filed: June 23, 2023
    Publication date: November 2, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
  • Publication number: 20230329650
    Abstract: An interactive graphical user interface associates information configured for interactive display and input, including patient identifying information for each patient in a patient list, a medication schedule for the each patient, and a treatment assessment worksheet comprising a display indicating the medical monitoring data for the each patient. The worksheet enables comparing monitoring results over different periods of time and development of treatment plans.
    Type: Application
    Filed: August 4, 2021
    Publication date: October 19, 2023
    Inventors: Aparajita Bhattacharya, Gary A. Hayter
  • Publication number: 20230293057
    Abstract: Methods and apparatus for acquiring data associated with a monitored analyte level, determining a glucose level based at least in part on the acquired data associated with the monitored analyte level, manipulating a data set based on a processing mode following the glucose level determination, where the processing mode includes one of a data set transmission and output display, a data set storing and output display without transmission, or a data set transmission and data set storing without output display are provided.
    Type: Application
    Filed: April 18, 2023
    Publication date: September 21, 2023
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Gary A. Hayter
  • Patent number: D1015366
    Type: Grant
    Filed: July 12, 2022
    Date of Patent: February 20, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Yashesvini V. Ram, Claire A. Cunningham, Justin N. Williams, William Koo Lee
  • Patent number: D1030780
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: June 11, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Erwin S. Budiman, Gary A. Hayter, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn Berman, Howard A. Wolpert
  • Patent number: D1038141
    Type: Grant
    Filed: April 21, 2022
    Date of Patent: August 6, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Panganamala Ashwin Kumar, Kimberly Hilton, Jessica Rose Floeh, Andrew M. Revoltar, Lindsey C. Swinehart, Vyshnnavi Parthasarathy, Addison Veronica Edwards-Gillas, Jonathan M. Fern, Matthew T. Novak, Gary A. Hayter